DC Funds, LP — 13F Holdings & Portfolio

CIK 1869028 · latest 13F-HR filed 2026-08-14

DC Funds, LP manages $1.3M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are TCRX (49.27%), BRNS (33.82%), HOWL (16.92%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 0; 1 existing position rose in reported value and 1 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$1.3M

Long-equity book

Holdings
3

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+0 / −0 / ↑1 / ↓1

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 100%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated May 21, 2026.

Assets Under Management
$1.40B
Discretionary
$1.40B
Employees
18
Accounts
4
Address
99 CANAL CENTER PLAZA
SUITE 400
ALEXANDRIA, VA 22314
Phone
(202) 737-5220
Name Title / Status Ownership Type
CAMPBELL, THOMAS, JUSTIN ControlCHIEF EXECUTIVE OFFICER/PARTNER
since Mar 2016
75% or moreIndividual
DADY, TERESA, GAIL ControlPARTNER/CHIEF COMPLIANCE OFFICER
since Mar 2016
5–10%Individual
DC CAPITAL PARTNERS MANAGEMENT GP, L.L.C. ControlGENERAL PARTNER
since Mar 2016
Less than 5%Domestic Entity
LEE, KUN SEUNG ControlCHIEF FINANCIAL OFFICER
since Apr 2026
Less than 5%Individual
O'CONNOR, JAMES, MICHAEL ControlPARTNER
since Mar 2026
Less than 5%Individual
CAMPBELL, THOMAS, JUSTIN Control
Indirect owner via DC CAPITAL PARTNERS MANAGEMENT GP, L.L.C.
SOLE MEMBER
since Mar 2016
75% or moreIndividual
Ownership & leadership changes · 9 filings with changes since Mar 22, 2016

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

May 21, 2026 filing
  • AddedLEE, KUN SEUNG · CHIEF FINANCIAL OFFICER · Less than 5% · control person
  • ChangedO'CONNOR, JAMES, MICHAEL · title PARTNER AND CHIEF FINANCIAL OFFICER → PARTNER
Mar 27, 2026 filing
  • No longer listedTolbert, Matthew, Tate · CHIEF FINANCIAL OFFICER · Less than 5% · control person · listed since Jan 2025
  • Listed againO'CONNOR, JAMES, MICHAEL · PARTNER AND CHIEF FINANCIAL OFFICER · Less than 5% · control person
Mar 28, 2025 filing
  • No longer listedO'CONNOR, JAMES, MICHAEL · CHIEF FINANCIAL OFFICER · Less than 5% · control person · listed since Apr 2022
  • AddedTolbert, Matthew, Tate · CHIEF FINANCIAL OFFICER · Less than 5% · control person
Apr 1, 2022 filing
  • No longer listedBerta, Catherine · CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Apr 2018
  • ChangedDADY, TERESA, GAIL · title PARTNER → PARTNER/CHIEF COMPLIANCE OFFICER
Mar 31, 2022 filing
  • AddedO'CONNOR, JAMES, MICHAEL · CHIEF FINANCIAL OFFICER · Less than 5% · control person
Mar 31, 2021 filing
  • No longer listedLAKE, DOUGLAS, THOMAS · PARTNER · 10–25% · control person · listed since Mar 2016
Oct 2, 2018 filing
  • AddedBerta, Catherine · CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedCAMPBELL, THOMAS, JUSTIN · title CHIEF EXECUTIVE OFFICER → CHIEF EXECUTIVE OFFICER/PARTNER
  • ChangedDADY, TERESA, GAIL · title CHIEF COMPLIANCE OFFICER/ PARTNER → PARTNER
  • ChangedLAKE, DOUGLAS, THOMAS · title CHIEF FINANCIAL OFFICER → PARTNER
Mar 29, 2018 filing
  • ChangedCAMPBELL, THOMAS, JUSTIN · title CHIEF EXECUTIVE OFFICER/ OWNER → CHIEF EXECUTIVE OFFICER
Mar 27, 2017 filing
  • ChangedDADY, TERESA, GAIL · title PARTNER → CHIEF COMPLIANCE OFFICER/ PARTNER
  • ChangedLAKE, DOUGLAS, THOMAS · title CHIEF COMPLIANCE OFFICER/ CHIEF FINANCIAL OFFICER → CHIEF FINANCIAL OFFICER
Mar 22, 2016 filing (earliest on record)
  • ListedCAMPBELL, THOMAS, JUSTIN · CHIEF EXECUTIVE OFFICER/ OWNER · 75% or more · control person
  • ListedCAMPBELL, THOMAS, JUSTIN · SOLE MEMBER · 75% or more · indirect via DC CAPITAL PARTNERS MANAGEMENT GP, L.L.C. · control person
  • ListedDADY, TERESA, GAIL · PARTNER · 5–10% · control person
  • ListedDC CAPITAL PARTNERS MANAGEMENT GP, L.L.C. · GENERAL PARTNER · Less than 5% · control person
  • ListedLAKE, DOUGLAS, THOMAS · CHIEF COMPLIANCE OFFICER/ CHIEF FINANCIAL OFFICER · 10–25% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 1 →

Top Trims

Show all 1 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • No exits this quarter.
Show all 0 →

DC Funds, LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 TSCAN THERAPEUTICS INC TCRX 89854M101 $617.5K 49.27% 630,000 SH
2 BARINTHUS BIOTHERAPEUTICS PL BRNS 91864C107 $423.9K 33.82% 642,204 SH
3 WEREWOLF THERAPEUTICS INC HOWL 95075A107 $212.0K 16.92% 589,102 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.3M 3 0001398344-26-014487
2026-03-31 2026-05-14 $1.5M 3 0001398344-26-009112
2025-12-31 2026-02-13 $1.5M 3 0001398344-26-002970
2025-09-30 2025-11-10 $3.1M 3 0001398344-25-020563
Filer Information
Address
1600 TYSONS BOULEVARD
FIFTH FLOOR
MCLEAN, VA 22102
Phone
(703) 760-4400
Filing Manager
DC Funds, LP
MCLEAN, VA
Signatory
Dean L. Wilde II
Managing Director and CEO